Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $429.13 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $199.55 | 3 | $0 (2024) |
| Avadel Specialty Pharmaceuticals, LLC | $50.90 | 3 | $0 (2018) |
| Laborie Medical Technologies Corp. | $43.06 | 1 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $42.39 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $38.94 | 2 | $0 (2023) |
| Progenics Pharmaceuticals, Inc. | $28.30 | 1 | $0 (2023) |
| ABC Home Medical Supply, Inc. | $13.14 | 1 | $0 (2023) |
| Teleflex LLC | $12.85 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $188.96 | 2 | Dendreon Pharmaceuticals LLC ($145.90) |
| 2023 | $61.25 | 3 | Progenics Pharmaceuticals, Inc. ($28.30) |
| 2022 | $31.98 | 2 | AstraZeneca Pharmaceuticals LP ($19.13) |
| 2021 | $42.39 | 1 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($42.39) |
| 2019 | $23.28 | 1 | Dendreon Pharmaceuticals LLC ($23.28) |
| 2018 | $81.27 | 4 | Avadel Specialty Pharmaceuticals, LLC ($50.90) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $145.90 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 05/20/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $43.06 | General |
| Category: Urology | ||||||
| 08/02/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 02/14/2023 | ABC Home Medical Supply, Inc. | — | Food and Beverage | In-kind items and services | $13.14 | General |
| 01/13/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Oncology | ||||||
| 12/06/2022 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Interventional Urology | ||||||
| 12/05/2022 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Oncology | ||||||
| 07/02/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $42.39 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/10/2019 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/19/2018 | Avadel Specialty Pharmaceuticals, LLC | Noctiva (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Urology | ||||||
| 11/09/2018 | Avadel Specialty Pharmaceuticals, LLC | Noctiva (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Urology | ||||||
| 05/16/2018 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $30.37 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 04/13/2018 | Avadel Specialty Pharmaceuticals, LLC | Noctiva (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 939 | 1,004 | $1.1M | $116,028 |
| 2022 | 7 | 866 | 940 | $1.1M | $129,949 |
| 2021 | 7 | 682 | 749 | $997,167 | $122,325 |
| 2020 | 7 | 553 | 609 | $625,165 | $79,377 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 397 | 434 | $572,012 | $61,934 | 10.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 200 | 211 | $375,158 | $37,935 | 10.1% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 95 | 103 | $93,318 | $9,442 | 10.1% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2023 | 24 | 24 | $13,924 | $2,757 | 19.8% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 30 | 30 | $31,830 | $2,066 | 6.5% |
| 93042 | Electrocardiogram (ecg) 1 to 3 leads with review by physician only | Facility | 2023 | 178 | 187 | $15,708 | $1,011 | 6.4% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 15 | 15 | $7,170 | $883.50 | 12.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 255 | 278 | $494,232 | $59,574 | 12.1% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 313 | 347 | $457,346 | $58,531 | 12.8% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 44 | 46 | $41,676 | $5,135 | 12.3% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2022 | 20 | 21 | $12,163 | $2,276 | 18.7% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 27 | 28 | $29,677 | $1,878 | 6.3% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 24 | 25 | $11,950 | $1,455 | 12.2% |
| 93042 | Electrocardiogram (ecg) 1 to 3 leads with review by physician only | Facility | 2022 | 183 | 195 | $16,380 | $1,101 | 6.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 339 | 392 | $512,526 | $64,252 | 12.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 211 | 221 | $392,938 | $47,325 | 12.0% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 52 | 53 | $47,188 | $5,821 | 12.3% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2021 | 19 | 19 | $9,021 | $2,289 | 25.4% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older, not tunneled | Facility | 2021 | 24 | 25 | $26,308 | $1,801 | 6.8% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 14 | 15 | $7,170 | $701.61 | 9.8% |
| 93042 | Interpretation and report of electrical activity of heart using 1-3 leads | Facility | 2021 | 23 | 24 | $2,016 | $135.93 | 6.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 305 | 346 | $376,200 | $52,412 | 13.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 80 | 82 | $145,796 | $17,248 | 11.8% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 52 | 61 | $45,140 | $5,936 | 13.1% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older | Facility | 2020 | 29 | 29 | $30,583 | $2,112 | 6.9% |
About Dr. Christopher Ng, MD
Dr. Christopher Ng, MD is a Emergency Medicine healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790711588.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Ng, MD has received a total of $429.13 in payments from pharmaceutical and medical device companies, with $188.96 received in 2024. These payments were reported across 13 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($429.13).
As a Medicare-enrolled provider, Ng has provided services to 3,040 Medicare beneficiaries, totaling 3,302 services with total Medicare billing of $447,678. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Internal Medicine
- Location Los Angeles, CA
- Active Since 06/23/2006
- Last Updated 03/15/2017
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1790711588
Products in Payments
- PROVENGE (Drug) $199.55
- Noctiva (Drug) $50.90
- Optilume BPH Drug Coated Balloon Catheter (Device) $43.06
- LifeVest (Device) $42.39
- IMFINZI (Biological) $38.94
- PYLARIFY (Drug) $28.30
- UROLIFT (Device) $12.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Los Angeles
Dr. Christopher Peabody, Md, Mph, MD, MPH
Emergency Medicine — Payments: $168,692
Dr. Luis Abrishamian-Garcia, Md, MD
Emergency Medicine — Payments: $98,157
Dr. Samuel Beckerman, M.d., Ph.d, M.D., PH.D
Emergency Medicine — Payments: $80,910
Patrick Mcgarry, M.d, M.D
Emergency Medicine — Payments: $19,968
Dr. Sonia Johnson, M.d, M.D
Emergency Medicine — Payments: $17,450
Dr. Sanjay Arora
Emergency Medicine — Payments: $15,018